GlassScriptPhysician profile
William L Abraham
NPI 1669468195
$2,084.20
in general payments reported to CMS, 2019-2025
20 companies · $685 in 2025
The $685 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $25.13 · 2021: $51.39 · 2022: $120 · 2023: $542 · 2024: $507 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,734.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $658.73 | 2019-2025 | Xtampza, Belbuca |
| Medtronic, INC. | $274.67 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $227.34 | 2022-2025 | Relistor |
| Boston Scientific Corporation | $155.43 | 2023-2025 | Intracept |
| Abbvie INC. | $152.91 | 2023-2025 | Qulipta, Botox |
| Averitas Pharma INC. | $138.67 | 2023-2025 | Qutenza |
| Nevro Corp. | $70.67 | 2021-2022 | |
| Lundbeck LLC | $60.86 | 2024-2025 | Vyepti |
| Pfizer INC. | $58.56 | 2019-2025 | |
| Protega Pharmaceutials INC | $48.25 | 2025 | Roxybond |
| Vertos Medical, INC. | $43.18 | 2024 | Mild Device Kit |
| Vertex Pharmaceuticals Incorporated | $37.57 | 2025 | |
| Lilly USA, LLC | $34.32 | 2022-2024 | Emgality |
| Relievant Medsystems, INC. | $25.13 | 2020 | |
| Pacira Therapeutics, INC. | $20.59 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $18.87 | 2024 | Movantik |
| Phathom Pharmaceuticals, INC. | $17.88 | 2025 | Voquezna |
| Nalu Medical, INC. | $15.67 | 2024 | Nalu Neurostimulation System |
| Scilex Pharmaceuticals INC. | $13.66 | 2023 | Ztlido |
| Radius Health, INC. | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.